Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03409458
Title A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab (PAVE-1)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Phosplatin Therapeutics

lung non-small cell carcinoma

prostate cancer

breast cancer

transitional cell carcinoma

head and neck squamous cell carcinoma


Avelumab + Imifoplatin

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.